Chronic obstructive pulmonary disease and lung cancer: access to palliative care, emergency room visits and hospital deaths.


Journal

BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563

Informations de publication

Date de publication:
19 May 2021
Historique:
received: 09 03 2021
accepted: 07 05 2021
entrez: 20 5 2021
pubmed: 21 5 2021
medline: 19 11 2021
Statut: epublish

Résumé

Despite the severe symptoms experienced by dying COPD patients, specialized palliative care (SPC) services focus mainly on cancer patients. We aimed to study the access to SPC that COPD and lung cancer (LC) patients receive and how that access affects the need for acute hospital care. A descriptive regional registry study using data acquired through VAL, the Stockholm Regional Council's central data warehouse, which covers nearly all healthcare use in the county of Stockholm. All the patients who died of COPD or LC from 2015 to 2019 were included. T-tests, chi-2 tests, and univariable and multivariable logistic regression analyses were performed on the accumulated data. In total, 6479 patients, (2917 with COPD and 3562 with LC) were studied. The patients with LC had more access to SPC during the last three months of life than did those with COPD (77% vs. 18%, respectively; p < .0001), whereas patients with COPD were more likely to be residents of nursing homes than those with LC (32% vs. 9%, respectively; p < .0001). Higher socioeconomic status (SES) (p < .01) and patient age < 80 years (p < .001) were associated with increased access to SPC for LC patients. Access to SPC correlated with fewer emergency room visits (p < .0001 for both COPD and LC patients) and fewer admissions to acute hospitals during the last month of life (p < .0001 for both groups). More COPD patients died in acute hospitals than lung cancer patients, (39% vs. 20%; χ Compared to dying COPD patients, LC patients have more access to SPC. Access to SPC reduces the need for emergency room visits and admissions to acute hospitals.

Sections du résumé

BACKGROUND BACKGROUND
Despite the severe symptoms experienced by dying COPD patients, specialized palliative care (SPC) services focus mainly on cancer patients. We aimed to study the access to SPC that COPD and lung cancer (LC) patients receive and how that access affects the need for acute hospital care.
METHODS METHODS
A descriptive regional registry study using data acquired through VAL, the Stockholm Regional Council's central data warehouse, which covers nearly all healthcare use in the county of Stockholm. All the patients who died of COPD or LC from 2015 to 2019 were included. T-tests, chi-2 tests, and univariable and multivariable logistic regression analyses were performed on the accumulated data.
RESULTS RESULTS
In total, 6479 patients, (2917 with COPD and 3562 with LC) were studied. The patients with LC had more access to SPC during the last three months of life than did those with COPD (77% vs. 18%, respectively; p < .0001), whereas patients with COPD were more likely to be residents of nursing homes than those with LC (32% vs. 9%, respectively; p < .0001). Higher socioeconomic status (SES) (p < .01) and patient age < 80 years (p < .001) were associated with increased access to SPC for LC patients. Access to SPC correlated with fewer emergency room visits (p < .0001 for both COPD and LC patients) and fewer admissions to acute hospitals during the last month of life (p < .0001 for both groups). More COPD patients died in acute hospitals than lung cancer patients, (39% vs. 20%; χ
CONCLUSIONS CONCLUSIONS
Compared to dying COPD patients, LC patients have more access to SPC. Access to SPC reduces the need for emergency room visits and admissions to acute hospitals.

Identifiants

pubmed: 34011344
doi: 10.1186/s12890-021-01533-3
pii: 10.1186/s12890-021-01533-3
pmc: PMC8132345
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

170

Références

Ann Am Thorac Soc. 2016 May;13(5):684-9
pubmed: 26784137
Eur Respir J. 2017 Mar 6;49(3):
pubmed: 28182564
Am J Hosp Palliat Care. 2021 Jan 11;:1049909120985419
pubmed: 33423532
Palliat Med. 2020 Sep;34(8):1030-1043
pubmed: 32484762
Int J Chron Obstruct Pulmon Dis. 2017 Jun 09;12:1721-1729
pubmed: 28652724
J Am Geriatr Soc. 2016 Sep;64(9):1815-22
pubmed: 27534517
Int J Chron Obstruct Pulmon Dis. 2019 Jul 31;14:1691-1701
pubmed: 31534323
Ups J Med Sci. 2013 Aug;118(3):181-6
pubmed: 23710665
Ups J Med Sci. 2019 Apr;124(2):140-147
pubmed: 31012800
Lancet. 2009 Aug 29;374(9691):704-11
pubmed: 19716962
J Pain Symptom Manage. 2018 Sep;56(3):318-326.e7
pubmed: 29902554
Epidemiology. 2007 Nov;18(6):805-35
pubmed: 18049195
Ups J Med Sci. 2020 Nov;125(4):297-304
pubmed: 33100083
Prim Care Respir J. 2012 Sep;21(3):295-301
pubmed: 22786813
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
J Palliat Care. 2018 Apr;33(2):109-114
pubmed: 29514555
Int J Chron Obstruct Pulmon Dis. 2020 Jun 25;15:1495-1505
pubmed: 32612357
N Engl J Med. 2004 Mar 4;350(10):1005-12
pubmed: 14999112
Eur Respir J. 2006 Dec;28(6):1245-57
pubmed: 17138679
J Pain Symptom Manage. 2019 May;57(5):933-943
pubmed: 30708124
Respiration. 2014;88(3):208-14
pubmed: 25115178
J Palliat Med. 2020 Nov;23(11):1460-1467
pubmed: 32286904
Basic Clin Pharmacol Toxicol. 2019 Oct;125(4):360-369
pubmed: 31188534
BMJ. 2019 Oct 4;367:l5358
pubmed: 31585960
Int J Chron Obstruct Pulmon Dis. 2017 Jul 31;12:2239-2256
pubmed: 28814852

Auteurs

Peter Strang (P)

Department of Oncology-Pathology, Karolinska Institutet, Regional Cancer Centre in Stockholm, Gotland, Sweden. peter.strang@ki.se.
R & D Department, Stockholms Sjukhem Foundation, P.O. Box 12230, 102 26, Stockholm, Sweden. peter.strang@ki.se.

Per Fürst (P)

R & D Department, Stockholms Sjukhem Foundation, P.O. Box 12230, 102 26, Stockholm, Sweden.
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Christel Hedman (C)

R & D Department, Stockholms Sjukhem Foundation, P.O. Box 12230, 102 26, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Jenny Bergqvist (J)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Surgery, Capio St Görans Sjukhus, Stockholm, Sweden.

Helena Adlitzer (H)

Regional Cancer Centre in Stockholm, Gotland, Sweden.

Torbjörn Schultz (T)

R & D Department, Stockholms Sjukhem Foundation, P.O. Box 12230, 102 26, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH